Edward Trautner (1890-1978), a pioneer of psychopharmacology.
J Hist Neurosci
; 33(1): 1-56, 2024.
Article
en En
| MEDLINE
| ID: mdl-37862283
This article examines the scientific career of Edward Trautner, who did pioneering research in the 1950s on lithium treatment for psychiatric disorders. Trautner was the first scientist to study the mechanism of action of lithium as a psychiatric medication. His research established that lithium could be used safely and rationally, and anticipated by a decade the large volume of research in the 1960s and 1970s that led to international acceptance of lithium treatment for mood disorders. Trautner was a pioneer of biological psychiatry who considered pharmacology to be a useful therapeutical tool rather than a permanent cure for putative chemical imbalances. His research involved cross-disciplinary collaborations that combined clinical and laboratory research in the disciplines of psychiatry, physiology, biochemistry, teratology, and even oncology. Trautner himself had a multidisciplinary background that included publications in literature and philosophy.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Médicos
/
Psiquiatría
/
Psicofarmacología
Límite:
Humans
Idioma:
En
Revista:
J Hist Neurosci
Asunto de la revista:
HISTORIA DA MEDICINA
/
NEUROLOGIA
Año:
2024
Tipo del documento:
Article
País de afiliación:
Irlanda
Pais de publicación:
Reino Unido